CAJ | 학술논문

目的：探讨中西医结合应用治疗原发性肝癌的临床效果。方法：2007年1月～2010年1月在我院诊治的原发性肝癌患者154例，随机分为观察组(77例)和对照组(77例)，观察组患者在介入化疗栓塞治疗基础上行中医治疗，对照组患者进行介入化疗栓塞治疗。结果：观察组患者治疗有效率59.74%，对照组治疗有效率58.44%；患者胃肠道反应发生率、白细胞降低发生率、行为稳定率、生存期观察组分别为：37.66%、48.05%、64.93%、(5.12±3.27)月，对照组分别为：63.64%、70.13%、59.74%、(4.97±2.95)月。结论：中西医结合治疗能够减少介入化疗栓塞治疗原发性肝癌的不良反应，提高患者生活质量，但未改善患者临床疗效和生存期。
목적：탐토중서의결합응용치료원발성간암적림상효과。방법：2007년1월～2010년1월재아원진치적원발성간암환자154례，수궤분위관찰조(77례)화대조조(77례)，관찰조환자재개입화료전새치료기출상행중의치료，대조조환자진행개입화료전새치료。결과：관찰조환자치료유효솔59.74%，대조조치료유효솔58.44%；환자위장도반응발생솔、백세포강저발생솔、행위은정솔、생존기관찰조분별위：37.66%、48.05%、64.93%、(5.12±3.27)월，대조조분별위：63.64%、70.13%、59.74%、(4.97±2.95)월。결론：중서의결합치료능구감소개입화료전새치료원발성간암적불량반응，제고환자생활질량，단미개선환자림상료효화생존기。
Objective: To investigate the primary liver cancer treatment clinical effect of Integrative Medicine applications. Methods:154 cases of primary liver cancer patients in our hospital January 2007 to January 2010, Were randomly divided into observation group (77 cases) and control group (77 cases), the patients in the interventional chemoembolization based on the uplink Chinese medicine treatment, the control group patients with interventional chemoembolization therapy. Results: The patients efficiency of 59.74%, the control group was 58.44%; Patients with gastrointestinal reactions incidence of leukopenia incidence of behavioral stability rate, the lifetime of the observation group were: 37.66%, 48.05%, 64.93%, (5.12±3.27) months, the control group were: 63.64%, 70.13%59.74% (4.97±2.95) months. Conclusion: Integrative Medicine can reduce the interventional chemoembolization treatment of primary liver adverse reactions,Improve the quality of life of patients, but did not improve clinical response and survival.